\esprimed is a specialized expertise company in the fields of radioprotection and medical imaging. Founded in 2009 and headquartered in France, the company provides services and tools to optimize dose and image quality for imaging facilities, both public and private. Its activities revolve around three main axes and a transversal offer: optimization of dose and image quality in conventional radiology, interventional radiology, and CT scanning; limitation of operator dose (radiation protection for personnel); quality control and monitoring of devices in nuclear medicine; and training in medical imaging and awareness of radioprotection. esprimed has been engaged in an ambitious R&D strategy since 2011, partnering with the Gustave-Roussy Institute of Cancerology (IGR) and the Atomic Energy Commission (CEA). As of now, there is no public information available regarding the last investment or the investors involved.
There is no investment information
No recent news or press coverage available for esprimed.